Lack of Association Between Tumor Oxygenation and Cell Cycle Distribution or Proliferation Kinetics in Experimental Sarcomas

  • Oliver Thews
  • Debra K. Kelleher
  • Peter Vaupel
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 540)

Abstract

In tumor cells, pronounced hypoxia induces an arrest of cell cycle in the late G1phase1−3. Since hypoxia is a common phenomenon in experimental and human tumors the hypoxia-induced disturbance of the cell cycle may play a role in the reduced efficacy of non-surgical treatment modalities resulting in a reduced long-term prognosis and a higher rate of local recurrences in hypoxic tumors4,5. It has been shown that a cell cycle arrest reduces the efficacy of standard radiotherapy6,7 and may alter the cytotoxic effects of various chemotherapeutic agents such as cisplatin, alkylating agents, doxorubicin or taxols8−12 and of cytokines13. If tumor hypoxia plays a relevant role in affecting the cell cycle under in vivo conditions, then modulation of the oxygenations status (e.g., by breathing hyperoxic gases) may increase the efficacy of these treatments.

Keywords

Oxygenation Status Cell Cycle Distribution BrdU Incorporation Tumor Hypoxia Tumor Oxygenation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    T. Fujii, T. Otsuki, T. Moriya, H. Sakaguchi, J. Kurebayashi, K. Yata, M. Uno, T. Kobayashi, T. Kimura, Y. Jo, K. Kinugawa, Y. Furukawa, M. Morioka, A. Ueki, and H. Tanaka, Effect of hypoxia on human seminoma cells, Int.lOncol. 20, 955–962 (2002).Google Scholar
  2. 2.
    A. Krtolica, N.A. Krucher, and J.W. Ludlow, Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells, Br.J.Cancer 80, 1875–1883 (1999).PubMedCrossRefGoogle Scholar
  3. 3.
    Y. Ogiso, A. Tomida, H.D. Kim, and T. Tsuruo, Glucose starvation and hypoxia induce nuclear accumulation of proteasome in cancer cells, Biochem.Biophys.Res.Commun. 258, 448–452 (1999).PubMedCrossRefGoogle Scholar
  4. 4.
    M. Hbckel, K. chlenger, B. Aral, M. Mitze, U. Schäffer, and P. Vaupel, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix, Cancer Res. 56, 4509–4515 (1996).Google Scholar
  5. 5.
    M. HSckel and P. Vaupel, Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects, J. Nat/. Cancer Inst. 93, 266–276 (2001).CrossRefGoogle Scholar
  6. 6.
    C.D. Coleman, Clinical Applications of Molecular Biology in Radiation Oncology, Semin.Radiat.Oncol. 6, 245–249 (1996).PubMedCrossRefGoogle Scholar
  7. 7.
    E.J. Hall, Radiobiology for the Radiologist, 5 Ed. (J.B. Lippincott, Philadelphia, 2000 ).Google Scholar
  8. 8.
    M. Kartalou and J. M.Essigmann, Mechanisms of resistance to cisplatin, Mutat.Res. 478, 23–43 (2001).PubMedCrossRefGoogle Scholar
  9. 9.
    C.K. Luk, L. Veinot-Drebot, E. Tjan, and I.F. Tannock, Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines, J.Natl.Cancer Inst. 82, 684–692 (1990).PubMedCrossRefGoogle Scholar
  10. 10.
    D. Murray and R.E. Meyn, Cell cycle-dependent cytotoxicity of alkylating agents: determination of nitrogen mustard-induced DNA cross-links and their repair in Chinese hamster ovary cells synchronized by centrifugal elutriation, Cancer Res. 46, 2324–2329 (1986).PubMedGoogle Scholar
  11. 11.
    E.K. Rowinsky, M.J. Citardi, D.A. Noe, and R.C. Donehower, Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine, ICancer Res.Clin.Oncol. 119, 727–733 (1993).CrossRefGoogle Scholar
  12. 12.
    A. Tomida and T. Tsuruo, Drug resistance mediated by cellular stress response to the microenvironment of solid tumors, Anticancer Drug Des 14, 169–177 (1999).PubMedGoogle Scholar
  13. 13.
    A.A. Loosdrecht, G.J. Ossenkoppele, R.H. Beelen, M.G. Broekhoven, and M.M. Langenhuijsen, Cell cycle specific effects of tumor necrosis factor alpha in monocyte mediated leukemic cell death and the role of beta 2-integrins, Cancer Res. 53, 4399 - 4407 (1993).PubMedGoogle Scholar
  14. 14.
    O. Amellem and E.O. Pettersen, Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage, Cell Prolif. 24, 127 - 141 (1991).PubMedCrossRefGoogle Scholar
  15. 15.
    D.J. Chaplin, P.L. Olive, and R.E. Durand, Intermittent blood flow in a murine tumor: radiobiological effects, Cancer Res. 47, 597 - 601 (1987).PubMedGoogle Scholar
  16. 16.
    A.S. Kennedy, J.A. Raleigh, G.M. Perez, D.P. Calkins, D.E. Thrall, D.B. Novotny; and M.A. Varia, Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays, Int.J.Radiat.Oncal.Biol.Phys. 37, 897 - 905 (1997).CrossRefGoogle Scholar
  17. 17.
    M. Nordsmark, M. Hoyer, J. Keller, O.S. Nielsen, O.M. Jensen, and J. Overgaard, The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas, Int.J.Radiat.Oncol.Biol.Phys. 35, 701 - 708 (1996).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Oliver Thews
  • Debra K. Kelleher
  • Peter Vaupel
    • 1
  1. 1.Institute of Physiology and PathophysiologyUniversity of MainzMainzGermany

Personalised recommendations